In one paragraphArticle in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Alejandro Zamora-VélezGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.ORCID 0000-0003-4258-000X Derly Lorena VanegasGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.
María Camila FernándezGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.
Gerardo RamosGICOC (Grupo de Investigación en Compuestos Organometálicos y Catálisis), Programa de Química, Facultad de Ciencias Básicas, Universidad del Quindio, Armenia 630004, Colombia.ORCID 0000-0002-8737-6400 Edwar CortésGIPRONUT (Grupo de Investigación en Productos Naturales), Programa de Química, Facultad de Ciencias, Universidad del Tolima, Ibagué 730002, Colombia.ORCID 0000-0002-2302-0931 Ailan Farid ArenasGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.ORCID 0000-0002-0331-5556 Néstor CardonaGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.ORCID 0000-0002-6967-165X Jessica Palacio-RodriguezGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.
Juan David Valencia-HernandezGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.ORCID 0000-0002-9189-5684 Luz Angela VelozaGrupo Polifenoles, Facultad de Tecnología, Escuela de Química, Universidad Tecnológica de Pereira, Pereira 660003, Colombia.
Juan Carlos Sepúlveda-AriasGrupo Infección e Inmunidad, Facultad de Ciencias de la Salud, Universidad Tecnológica de Pereira, Pereira 660003, Colombia.ORCID 0000-0002-5410-5997 Jorge Enrique Gómez-MarínGEPAMOL (Grupo de Estudio en Parasitologia Molecular), Center for Biomedical Research (CIBM), Faculty of Health Sciences, University of Quindío, Armenia 630004, Colombia.ORCID 0000-0001-6472-3329 Funding
Sistema General de Regalías de Colombia BPIN 2020000100077University of Quindío Universidad del Quindío (100016837), grant number 1205
6 · The paper itselfAbstract
Concurrent evaluation of the antiparasitic efficacy of synthetic and natural compounds can provide novel insights into the development of anti-
Indexed as
pyrazolidinesTabebuiathiazolidinesToxoplasma
Identifiers
PMID41441586
PMCPMC12737779
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390